Related Experiment Videos
Propofol anaesthesia in malignant hyperpyrexia susceptible swine
P S Foster1, K C Hopkinson, M A Denborough
1Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT.
Clinical and Experimental Pharmacology & Physiology
|March 1, 1992
Summary
Propofol, a sedative, does not trigger malignant hyperpyrexia (MH) in susceptible pigs. It also did not induce muscle contracture in isolated MH-susceptible muscle, indicating safety for anesthesia.
Area of Science:
- Anesthesiology
- Pharmacology
- Muscle Physiology
Background:
- Malignant hyperpyrexia (MH) is a severe inherited muscle disorder.
- MH complications arise during general anesthesia.
- Propofol is a widely used anesthetic agent.
Purpose of the Study:
- To evaluate the safety of propofol in MH-susceptible individuals.
- To determine if propofol triggers MH or associated muscle responses.
Main Methods:
- Administered propofol to MH-susceptible pigs.
- Tested propofol's effect on isolated MH-susceptible muscle contracture.
- Compared propofol's effects with known MH triggers like halothane.
Main Results:
- Propofol did not induce malignant hyperpyrexia in susceptible pigs.
- Propofol did not cause contracture in isolated MH-susceptible muscle.
- Propofol modulated contractures induced by halothane, caffeine, and KCl.
Conclusions:
- Propofol appears to be a safe anesthetic agent for patients susceptible to malignant hyperpyrexia.
- Propofol does not directly trigger the MH myopathy.
- Further research may explore propofol's interaction with other anesthetic agents in MH patients.